Gene · 7083
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated analysis of WGCNA and machine learning identified diagnostic biomarkers in trauma-induced coagulopathy. | Sci Rep | 2025 | 40629026 | PubTator, text mining | PubMed |
| Tumor microenvironment-responsive dynamic self-assembly of DNAzyme nanowires for high-contrast imaging of multiple messenger RNAs and chemotherapy. | Biosens Bioelectron | 2025 | 40602092 | PubTator, text mining | PubMed |
| Thymidine Kinase 1 Expression Correlates with Tumor Aggressiveness and Metastatic Potential in OSCC. | Diagnostics (Basel) | 2025 | 40564887 | PubTator, text mining | PubMed |
| Single-Cell Profiling of the Microenvironment in High-Risk Neuroblastoma. | IUBMB Life | 2025 | 40536225 | PubTator, text mining | PubMed |
| Sodium Butyrate Enhances 5-Fluorouracil Sensitivity Through Thymidylate Synthase Regulation and Cell-Cycle Modulation in Gastric Cancer. | Mol Nutr Food Res | 2025 | 40519060 | PubTator, text mining | PubMed |
| The role of tumor microenvironment and immune cell crosstalk in triple-negative breast cancer (TNBC): Emerging therapeutic opportunities. | Cancer Lett | 2025 | 40516902 | PubTator, text mining | PubMed |
| Doxecitine and doxribtimine treatment in an adult patient with thymidine kinase 2 deficiency. | Mol Genet Metab | 2025 | 40516470 | PubTator, text mining | PubMed |
| The role of non-coding RNA regulates stem cell programmed death in disease therapy. | Noncoding RNA Res | 2025 | 40454168 | PubTator, text mining | PubMed |
| Characteristics of folic acid metabolism-related genes unveil prognosis and treatment strategy in lung adenocarcinoma. | BMC Pulm Med | 2025 | 40405133 | PubTator, text mining | PubMed |
| RNA m5C modification: from physiology to pathology and its biological significance. | Front Immunol | 2025 | 40370440 | PubTator, text mining | PubMed |
| A comprehensive review and in silico analysis of the role of survivin (BIRC5) in hepatocellular carcinoma hallmarks: A step toward precision. | Int J Biol Macromol | 2025 | 40306500 | PubTator, text mining | PubMed |
| RRM1 O-GlcNAcylation inhibition suppresses pancreatic cancer via TK1-mediated replication stress. | Cancer Gene Ther | 2025 | 40155654 | PubTator, text mining | PubMed |
| Thymidine kinase 1 concentration and activity in metastatic breast cancer under CDK4/6 inhibitor therapy. | Sci Rep | 2025 | 40133412 | PubTator, text mining | PubMed |
| Intramolecular enhanced entropy-driven DNA-Au nanodevice for mRNA imaging in living cells. | Mikrochim Acta | 2025 | 40095194 | PubTator, text mining | PubMed |
| Association of NR0B1 with Malignant Phenotypes in Esophageal Squamous Cell Carcinoma Through Modulation of p53-Independent Cell-Cycle Regulation. | Ann Surg Oncol | 2025 | 40080367 | PubTator, text mining | PubMed |
| Establishment and transcriptomic characteristics of radio-resistant meningioma cell lines. | J Neurooncol | 2025 | 40019713 | PubTator, text mining | PubMed |
| Thymidine kinase 1 indicates resistance to immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma. | Cell Oncol (Dordr) | 2025 | 40009128 | PubTator, text mining | PubMed |
| The SUMOylated RREB1 interacts with KDM1A to induce 5-fluorouracil resistance via upregulating thymidylate synthase and activating DNA damage response pathway in colorectal cancer. | MedComm (2020) | 2025 | 39991628 | PubTator, text mining | PubMed |
| KAT7-acetylated YBX1 promotes hepatocellular carcinoma proliferation by reprogramming nucleotide metabolism. | BMC Cancer | 2025 | 39984921 | PubTator, text mining | PubMed |
| Advancements in functional tetrahedral DNA nanostructures for multi-biomarker biosensing: Applications in disease diagnosis, food safety, and environmental monitoring. | Mater Today Bio | 2025 | 39935897 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7083/papers?page=5